Neuberger Berman Group LLC Invitae Corp Transaction History

Neuberger Berman Group LLC

  • $118 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024
BUY
$0.42 - $0.72 $3,723 - $6,383
8,866 Added 71.25%
21,309 $13,000
Q3 2023

Nov 14, 2023
SELL
$0.6 - $1.53 $4,064 - $10,364
-6,774 Reduced 35.25%
12,443 $7,000
Q2 2023

Aug 11, 2023
BUY
$1.05 - $1.63 $20,177 - $31,323
19,217 New
19,217 $21,000

Others Institutions Holding NVTA

# of Institutions
56
Shares Held
7.66M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email